Spatial Accessibility Modeling of Vaccine Deserts as Barriers to Controlling SARS-CoV-2 Transmission
Rader, B.; Astley, C. M.; Sewalk, K.; Delamater, P. L.; Cordiano, K.; Wronski, L.; Rivera, J. M.; Hallberg, K.; Pera, M. F.; Cantor, J.; Whaley, C.; Bravata, D.; Brownstein, J. S.
Show abstract
SARS-CoV-2 vaccine distribution is at risk of further propagating the inequities of COVID-19, which in the United States (US) has disproportionately impacted the elderly, people of color, and the medically vulnerable. We identify vaccine deserts - US Census tracts with localized, geographic barriers to vaccine-associated herd immunity - using a comprehensive supply database (VaccineFinder) and an empirically parameterized model of spatial access to essential resources. Incorporating high-resolution COVID-19 burden and time-willing-to-travel for vaccination, we show that early (February - March 2021) vaccine allocation disadvantaged rural and medically vulnerable populations. Data-driven vaccine distribution to vaccine deserts may improve immunization in the hesitant and control SARS-CoV-2.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: a multi-model study 93%
- Impact of healthcare capacity disparities on the COVID-19 vaccination coverage in the United States 93%
- Time-Varying Effectiveness of Three Covid-19 Vaccines in Puerto Rico 92%
Similar papers in this journal
Similar papers in this journal
- The Joint Impact of COVID-19 Vaccination and Non-Pharmaceutical Interventions on Infections, Hospitalizations, and Mortality: An Agent-Based Simulation 93%
- Estimation of COVID-19 cases prevented by vaccination in California 93%
- Health impact and cost of COVID-19 prophylaxis with monoclonal antibodies 93%
Similar papers in this journal
- Did COVID-19 Vaccines Go to the Whitest Neighborhoods First? Racial Inequities in Six Million Phase 1 Doses Shipped to Pennsylvania 95%
- COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact 94%
- Comparison of COVID-19 vaccine prioritization strategies in the United States 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.